Back Stocks profile

Stock analysis tool for investors

Nectar Lifesciences Ltd.

NSE: NECLIFE | BSE:532649

₹30.93 -0.49 (-1.56%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

30.70

Today’s High

31.80

52W low

19.80

52W High

45.70

Open Price

31.40

Prev. Close

30.7500

Volume

463315.00

Value

14330332.95

Fundamentals

Market Cap Cr

693.60

Price to Earnings

138.90

Price to Book Value

0.60

Dividend Yield

0.00

PE to Growth

1.20

Op Revenue TTM Cr

1685.63

Net Profit TTM Cr

4.99

Cash From Operating Activity Cr

224.69

Return on Equity %

0.46

EMA & SMA

Bullish Moving Averages

0

Bearish Moving Averages

16

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

04 Jul, 2024

50.3

Week

52.4

Month

54.8

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

31.15

PIVOT

First Resistance

31.58

Second Resistance

32.22

Third Resistance

32.65

First Support

30.51

Second Support

30.08

Third Support

29.44

Relative Strength Index

40.84

Money Flow Index

39.57

MACD

-0.43

MACD Signal

-0.3

Average True Range

1.23

Average Directional Index

16.63

Rate of Change (21)

6.29

Rate of Change (125)

-10.61

Commodity Channel Index

-91

Williams %R

-89

BETA

1 Month

1.35

3 Month

1.11

1 Year

0.94

3 Year

0.49

PRICE CHANGE ANALYSIS

-3.22%

1 Week

Low

High

30.5

32.33

-4.24%

1 Month

Low

High

26.15

34.74

-12.26%

3 Months

Low

High

26.15

38.8

-9.69%

6 Months

Low

High

26.15

45.7

52.74%

1 Year

Low

High

19.8

45.7

Bigul
04 Jul 2024

NECTAR LIFESCIENCES LTD. - 532649 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please find attached herewith the certificate as per captioned regulations
Bigul
26 Jun 2024

NECTAR LIFESCIENCES LTD. - 532649 - Closure of Trading Window

Notice of Closure of Trading Window as per attached letter.
Bigul
17 May 2024

NECTAR LIFESCIENCES LTD. - 532649 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find attached herewith Annual Secretarial Compliance Report for the year ended on March 31, 2024
Bigul
16 May 2024

NECTAR LIFESCIENCES LTD. - 532649 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find attached herewith the copy of newspapers for publication of financial results of the Company for the quarter and financial year ended on March 31, 2024.
Bigul
15 May 2024

NECTAR LIFESCIENCES LTD. - 532649 - Board Meeting Outcome for Outcome Of Board Meeting

Outcome of Board Meeting - Reappointment of Cost Auditors and Secretarial Auditors
Bigul
08 May 2024

NECTAR LIFESCIENCES LTD. - 532649 - Board Meeting Intimation for Annual Audited Financial Results And Other Business Matters.

NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2024 ,inter alia, to consider and approve the Audited Financial Results for the Financial Year 2023-24, Financial Statements of the Company for the Financial Year 2023-24 and matters related thereto.
Bigul
06 Apr 2024

NECTAR LIFESCIENCES LTD. - 532649 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please find attached herewith the certificate as per captioned regulations
See all News

FAQs

The latest market price of Nectar Lifesciences Ltd. on NSE was Rs. 30.93 as of today.

The opening share price of Nectar Lifesciences Ltd. was Rs. 31.40 as of today.

The 52-week high share price of Nectar Lifesciences Ltd. was Rs. 45.70.

The 52 week low share price of Nectar Lifesciences Ltd. was Rs. 19.80.

Nectar Lifesciences Ltd. has a market cap of Rs. 693.60 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Nectar Lifesciences Ltd. is 1.20. Please refer to the Fundamentals section for further details.

The operating revenue for Nectar Lifesciences Ltd. in the last FY was Rs.  1685.63 crore. Please refer to the Financials section for further details.

The Net Profit for Nectar Lifesciences Ltd. in the last FY was Rs. 4.99 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Nectar Lifesciences Ltd. was on 2020-09-11 for Rs. 0.05 per share. According to today’s share price, the dividend yield of Nectar Lifesciences Ltd. stands at 0.00. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

The latest split issue declared by Nectar Lifesciences Ltd. was as of 2008-11-12. The split ratio declared in this issue was 10:1. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Nectar Lifesciences Ltd..

Close

Let's Open Free Demat Account